Drug Discovery Stocks List

Recent Signals

Date Stock Signal Type
2019-08-19 ADPT Upper Bollinger Band Walk Strength
2019-08-19 ATHX 20 DMA Resistance Bearish
2019-08-19 BASI Wide Range Bar Range Expansion
2019-08-19 BASI New 52 Week Closing High Bullish
2019-08-19 BASI Volume Surge Other
2019-08-19 BASI Expansion Breakout Bullish Swing Setup
2019-08-19 BASI New 52 Week High Strength
2019-08-19 BASI Pocket Pivot Bullish Swing Setup
2019-08-19 BBC MACD Bullish Signal Line Cross Bullish
2019-08-19 BBC Crossed Above 20 DMA Bullish
2019-08-19 BBC Crossed Above 200 DMA Bullish
2019-08-19 BCEL NR7 Range Contraction
2019-08-19 BLFS Lizard Bearish Bearish Day Trade Setup
2019-08-19 BLFS Stochastic Reached Overbought Strength
2019-08-19 BLFS Doji - Bearish? Reversal
2019-08-19 BLFS Shooting Star Candlestick Bearish
2019-08-19 BLRX 1,2,3 Retracement Bearish Bearish Swing Setup
2019-08-19 BLRX MACD Bullish Signal Line Cross Bullish
2019-08-19 BLRX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 BMRN 20 DMA Resistance Bearish
2019-08-19 BMRN MACD Bullish Signal Line Cross Bullish
2019-08-19 CLVS Narrow Range Bar Range Contraction
2019-08-19 CLVS NR7-2 Range Contraction
2019-08-19 CLVS NR7 Range Contraction
2019-08-19 CRIS NR7 Range Contraction
2019-08-19 CRIS Narrow Range Bar Range Contraction
2019-08-19 CRL Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 CRL Narrow Range Bar Range Contraction
2019-08-19 CRL NR7 Range Contraction
2019-08-19 CRL Stochastic Buy Signal Bullish
2019-08-19 DMPI Narrow Range Bar Range Contraction
2019-08-19 DMPI 1,2,3 Pullback Bullish Bullish Swing Setup
2019-08-19 DMPI Lower Bollinger Band Walk Weakness
2019-08-19 DMPI Calm After Storm Range Contraction
2019-08-19 DMPI New 52 Week Low Weakness
2019-08-19 DMPI New 52 Week Closing Low Bearish
2019-08-19 GE 180 Bearish Setup Bearish Swing Setup
2019-08-19 GLW NR7 Range Contraction
2019-08-19 GLW Narrow Range Bar Range Contraction
2019-08-19 GLYC Narrow Range Bar Range Contraction
2019-08-19 GNMX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-08-19 GNMX Boomer Buy Setup Bullish Swing Setup
2019-08-19 GNMX 180 Bullish Setup Bullish Swing Setup
2019-08-19 GNMX 1,2,3 Pullback Bullish Bullish Swing Setup
2019-08-19 GNMX Crossed Above 50 DMA Bullish
2019-08-19 GNMX 20 DMA Support Bullish
2019-08-19 HCM 1,2,3 Retracement Bearish Bearish Swing Setup
2019-08-19 HCM Fell Below 20 DMA Bearish
2019-08-19 HCM Shooting Star Candlestick Bearish
2019-08-19 HCM Doji - Bearish? Reversal
2019-08-19 HCM Bollinger Band Squeeze Range Contraction
2019-08-19 HCM Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 HSGX Bollinger Band Squeeze Range Contraction
2019-08-19 HSGX Pocket Pivot Bullish Swing Setup
2019-08-19 HSGX Crossed Above 20 DMA Bullish
2019-08-19 HTGC Crossed Above 20 DMA Bullish
2019-08-19 HTGC Crossed Above 50 DMA Bullish
2019-08-19 IDYA New 52 Week Closing Low Bearish
2019-08-19 IDYA Hammer Candlestick Bullish
2019-08-19 IDYA Doji - Bullish? Reversal
2019-08-19 IDYA Lizard Bullish Bullish Day Trade Setup
2019-08-19 IDYA New 52 Week Low Weakness
2019-08-19 IEX 50 DMA Resistance Bearish
2019-08-19 IEX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 IEX MACD Bullish Signal Line Cross Bullish
2019-08-19 INFI Pocket Pivot Bullish Swing Setup
2019-08-19 LXRX Narrow Range Bar Range Contraction
2019-08-19 MREO Upper Bollinger Band Walk Strength
2019-08-19 MREO Pocket Pivot Bullish Swing Setup
2019-08-19 PKI Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 PKI NR7 Range Contraction
2019-08-19 PKI Narrow Range Bar Range Contraction
2019-08-19 PKI 1,2,3 Retracement Bearish Bearish Swing Setup
2019-08-19 PRTA Lower Bollinger Band Walk Weakness
2019-08-19 SMMT Lower Bollinger Band Walk Weakness
2019-08-19 SMMT Doji - Bullish? Reversal
2019-08-19 SRRA Lower Bollinger Band Walk Weakness
2019-08-19 SRRA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 SRRA 1,2,3 Retracement Bearish Bearish Swing Setup
2019-08-19 SRRA Boomer Sell Setup Bearish Swing Setup
2019-08-19 STRO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 SUPN Slingshot Bearish Bearish Swing Setup
2019-08-19 SUPN Narrow Range Bar Range Contraction
2019-08-19 TWST NR7 Range Contraction
2019-08-19 TWST NR7-2 Range Contraction
2019-08-19 TWST 20 DMA Resistance Bearish
2019-08-19 UMRX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 UMRX Crossed Above 20 DMA Bullish
2019-08-19 VTGN 1,2,3 Retracement Bearish Bearish Swing Setup
2019-08-19 VTGN Pocket Pivot Bullish Swing Setup
2019-08-19 VTGN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 VTGN Crossed Above 20 DMA Bullish
2019-08-19 WAT Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-08-19 WAT Stochastic Buy Signal Bullish
2019-08-19 WAT 20 DMA Resistance Bearish

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery. Later chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that have a desirable therapeutic effect in a process known as
classical pharmacology. Since sequencing of the human genome which allowed rapid cloning and synthesis of large quantities of purified proteins, it has become common practice to use high throughput screening of large compounds libraries against isolated biological targets which are hypothesized to be disease modifying in a process known as reverse pharmacology. Hits from these screens are then tested in cells and then in animals for efficacy.
Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. Once a compound that fulfills all of these requirements has been identified, it will begin the process of drug development prior to clinical trials. One or more of these steps may, but not necessarily, involve computer-aided drug design. Modern drug discovery is thus usually a capital-intensive process that involves large investments by pharmaceutical industry corporations as well as national governments (who provide grants and loan guarantees). Despite advances in technology and understanding of biological systems, drug discovery is still a lengthy, "expensive, difficult, and inefficient process" with low rate of new therapeutic discovery. In 2010, the research and development cost of each new molecular entity was about US$1.8 billion. Drug discovery is done by pharmaceutical companies, with research assistance from universities. The "final product" of drug discovery is a patent on the potential drug. The drug requires very expensive Phase I, II and III clinical trials, and most of them fail. Small companies have a critical role, often then selling the rights to larger companies that have the resources to run the clinical trials.
Discovering drugs that may be a commercial success, or a public health success, involves a complex interaction between investors, industry, academia, patent laws, regulatory exclusivity, marketing and the need to balance secrecy with communication. Meanwhile, for disorders whose rarity means that no large commercial success or public health effect can be expected, the orphan drug funding process ensures that people who experience those disorders can have some hope of pharmacotherapeutic advances.

More about Drug Discovery